Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1999; 33:403-411
© 1999 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stevens, M. A.
Right arrow Articles by O’Neill, W. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stevens, M. A.
Right arrow Articles by O’Neill, W. W.

A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy

Results of the P.R.I.N.C.E. study

Melissa A. Stevens, MDa, Peter A. McCullough, MD, MPHa*,1, Kenneth J. Tobin, DOa, John P. Speck, MDa, Douglas C. Westveer, MD, FACCa, Debra A. Guido-Allen, BSNa, Gerald C. Timmis, MD, FACCa and William W. O’Neill, MD, FACCa

a William Beaumont Hospital, Royal Oak, Michigan, USA
* Henry Ford Health System, Detroit, Michigan, USA



View larger version (19K):

[in a new window]
 
Figure 1 Mean individual change in serum creatinine at 48 h in the control group and the two subsets of the experimental group. IVF = intravenous 0.45 normal saline at 150 ml/h for 6 h with upward adjustment for urine flow rates greater than 150 ml/h (control group). F = furosemide 1 mg/kg intravenously up to 100 mg at the start of the procedure. D = intravenous dopamine 3 mcg/kg/min at the start of the procedure and continued for 6 h. M = mannitol 12.5 g in 250 ml of 5% dextrose infused at the start of the procedure over a 2-h period. p = 0.21 by analysis of variance.

 


View larger version (30K):

[in a new window]
 
Figure 2 Change in postcontrast exposure serum creatinine at 48 h stratified by measured urine flow rate, n = 98 (to convert from mg/dl to µmol/liter, multiply by 88.4). p < 0.05 for comparison of 1st to 5th quintile.

 


View larger version (15K):

[in a new window]
 
Figure 3 Rates of renal failure shown by multiple definitions of the end point stratified over the cutpoint of 150 ml/h of urine flow induced by a forced diuresis, n = 98. {square} = Low UFR (less double equals150 ml/h); {blacksquare} = High UFR (>150 ml/h). {diamondsuit}p < 0.05. 1 indicates >25% rise in serum creatinine; 2 indicates >50% rise in serum creatinine; 3 indicates >100% rise in serum creatinine; 4 indicates >1.0 mg/dl rise in serum creatinine; 5 indicates a peak creatinine of >5.0 mg/dl at 48 h or dialysis. UFR = urine flow rate.

 


View larger version (23K):

[in a new window]
 
Figure 4 Regression of induced urine flow rate predicting resultant change in serum creatinine from baseline to that measured at 48 h in mg/dl, controlling for baseline renal function (to convert from mg/dl to µmol/liter, multiply by 88.4). This shows a relation between increasing urine flow rates in the first 24 h after contrast exposure and reduction in renal injury measured at 48 h that is independent of baseline renal function in all 98 aggregated participants, r = –0.36; F = 5.73; p = 0.005. Urine flow rate (ml/h), beta = –0.36; t = –3.33; p = 0.001. Baseline CrCl (ml/min), beta = 0.10; t = 0.93; p = 0.36.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement